Recurrent meningioma: Salvage therapy with long-acting somatostatin analogue (vol 69, pg 969, 2007)

被引：0
|
作者：
Chamberlain
机构：
来源：
NEUROLOGY | 2008年 / 70卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：325 / 325
页数：1
相关论文
共 50 条
  • [31] Treatment of advanced pancreatic cancer with the long-acting somatostatin analogue lanreotide: in vitro and in vivo results
    Raderer, M
    Hamilton, G
    Kurtaran, A
    Valencak, J
    Haberl, I
    Hoffmann, O
    Kornek, GV
    Vorbeck, F
    Hejna, MHL
    Virgolini, I
    Scheithauer, W
    BRITISH JOURNAL OF CANCER, 1999, 79 (3-4) : 535 - 537
  • [32] Treatment of postoperative dumping syndrome with the long-acting somatostatin analogue octreotide L.a.R
    Arts, Joris
    Holvoet, Lieselot
    Bisschops, Raf
    Caenepeel, Philippe
    Hubert, Piessevaux
    Bourgeois, Stefan
    Dewulf, Dominick
    Sifrim, Daniel
    Janssens, Jozef
    Tack, Jan
    GASTROENTEROLOGY, 2007, 132 (04) : A639 - A639
  • [33] Quantitative uptake in 99mTc-EDDA/HYNIC-TOC somatostatin receptor imaging - the effect of long-acting release somatostatin analogue therapy
    Gemmell, Alastair J.
    Brown, Colin M.
    Ray, Surajit
    Small, Alexander
    NUCLEAR MEDICINE COMMUNICATIONS, 2023, 44 (11) : 944 - 952
  • [34] LONG-ACTING SOMATOSTATIN ANALOG THERAPY AND PROTEIN-METABOLISM IN PATIENTS WITH JEJUNOSTOMIES
    OKEEFE, SJD
    HAYMOND, MW
    BENNET, WM
    OSWALD, B
    NELSON, DK
    SHORTER, RG
    GASTROENTEROLOGY, 1994, 107 (02) : 379 - 388
  • [35] Somatostatin receptor expression, tumour response and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide (vol 96, pg 1154, 2007)
    Cebon, J.
    Findlay, M.
    Hargreaves, C.
    Stockler, M.
    Thompson, P.
    Boyer, M.
    Roberts, S.
    Poon, A.
    Scott, A. M.
    Kalff, V.
    Garas, G.
    Dowling, A.
    Crawford, D.
    Ring, J.
    Basser, R.
    Strickland, A.
    Macdonald, G.
    Green, M.
    Nowak, A.
    Dickman, B.
    Dhillon, H.
    Gebski, V.
    BRITISH JOURNAL OF CANCER, 2007, 96 (07) : 1154 - 1154
  • [36] Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
    Christina Darden
    Mark Price
    David Ray
    Grace Goldstein
    Diana Goss
    Lee Bennett
    Diana Garbinsky
    Ramya Thota
    Journal of Patient-Reported Outcomes, 5
  • [37] Patients' satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
    Darden, Christina
    Price, Mark
    Ray, David
    Goldstein, Grace
    Goss, Diana
    Bennett, Lee
    Garbinsky, Diana
    Thota, Ramya
    JOURNAL OF PATIENT-REPORTED OUTCOMES, 2021, 5 (01)
  • [38] THERAPY OF APUDOMAS WITH LONG-ACTING SMS201-995 SOMATOSTATIN ANALOGS
    BRABANT, G
    MULLER, M
    HESCH, RD
    SCHMIDT, FW
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1985, 23 (09): : 414 - 414
  • [39] High-dose treatment with a long-acting somatostatin analogue in patients with advanced midgut carcinoid tumours
    Welin, SV
    Janson, ET
    Sundin, A
    Stridsberg, M
    Lavenius, E
    Granberg, D
    Skogseid, B
    Öberg, KE
    Eriksson, BK
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2004, 151 (01) : 107 - 112
  • [40] Rates of adverse events of long-acting Opioids in a state medicaid program (vol 41, pg 921, 2007)
    不详
    ANNALS OF PHARMACOTHERAPY, 2007, 41 (09) : 1552 - 1552
12345